A Case of Pharmaceutical Care of AIDS Patients with Disseminated Cryptococcus

目的:探讨临床药师在艾滋病合并播散性隐球菌病患者中的药学服务方法。方法:临床药师参与1例艾滋病合并播散性隐球菌病患者的药物治疗全过程,对抗真菌治疗、ART启动时机及方案、合并感染的抗菌药物选择及药物不良反应的处理及上报等方面进行了全程的药学监护。结果:患者顺利完成了抗真菌诱导期的治疗,病原学结果转阴,启动了ART,好转出院。结论:临床药师应积极参与到临床药物治疗中,开展药学服务,保障用药安全。Objective: To explore the pharmaceutical method of clinical paharmacists in patients with AIDS complicated with disseminated cryptococcus. Methods: Clinical paharmacists participated in the whole process of drug therapy for a case of AIDS patients with disseminated cryptococcus, and conducted pharmaceutical care in the whole process of antifungal therapy, the timing and program of ART initiation, the selection of antibacterial drugs for co-infection, the treatment and reporting of adverse drug reactions, etc. Results: The patient successfully completed the antifungal induction phase of treatment, the etiological results turned negative, ART was activated, and the patient was discharged with improvement. Conclusion: Clinical pharmacist should actively participate in clinical drug treatment, carry out pharmaceutical care, and ensure drug safety.

Authors

Publication Details

Journal
Medical Diagnosis
Published
2025-01-01
DOI
https://doi.org/10.12677/md.2025.153031
Primary Topic
Fungal Infections and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Pharmaceutical Care of AIDS Patients with Disseminated Cryptococcus

琰淇 彭
Medical Diagnosis
Fungal Infections and Studies
article

A Case of Pharmaceutical Care of AIDS Patients with Disseminated Cryptococcus

琰淇 彭
article en

Abstract

目的:探讨临床药师在艾滋病合并播散性隐球菌病患者中的药学服务方法。方法:临床药师参与1例艾滋病合并播散性隐球菌病患者的药物治疗全过程,对抗真菌治疗、ART启动时机及方案、合并感染的抗菌药物选择及药物不良反应的处理及上报等方面进行了全程的药学监护。结果:患者顺利完成了抗真菌诱导期的治疗,病原学结果转阴,启动了ART,好转出院。结论:临床药师应积极参与到临床药物治疗中,开展药学服务,保障用药安全。Objective: To explore the pharmaceutical method of clinical paharmacists in patients with AIDS complicated with disseminated cryptococcus. Methods: Clinical paharmacists participated in the whole process of drug therapy for a case of AIDS patients with disseminated cryptococcus, and conducted pharmaceutical care in the whole process of antifungal therapy, the timing and program of ART initiation, the selection of antibacterial drugs for co-infection, the treatment and reporting of adverse drug reactions, etc. Results: The patient successfully completed the antifungal induction phase of treatment, the etiological results turned negative, ART was activated, and the patient was discharged with improvement. Conclusion: Clinical pharmacist should actively participate in clinical drug treatment, carry out pharmaceutical care, and ensure drug safety.

Medical DiagnosisVol. 15(03)
Good health and well-being
Openalex Percentile: Top 82%
Fungal Infections and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.